Webdisclosure.com

Search

KAUFMAN & BROAD (EPA:KOF) Kaufman & Broad SA: AGM 6, May 2021 results

Directive transparence : information réglementée

20/05/2021 09:55

Kaufman & Broad SA
Kaufman & Broad SA: AGM 6, May 2021 results

20-May-2021 / 09:55 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


COMBINED ORDINARY AND EXTRAORDINARY

SHAREHOLDERS' MEETING

MAY 6, 2021

Number of shareholders present or reprensented to the meeting :

372

Number of shareholder shares present or represented to the meeting :

18,042,479  

Number of shareholder votes present or reprensented to the meeting :

 22,256,952  

 

 

GENERAL QUORUM reached

 

 

 

Resolutions

Result

Votes cast

Exclusions

For

Against

Forbearance

(in number and proportion

(in number and proportion

(in number and proportion

(in number and proportion

(in number and proportion

of votes

of votes

of votes

of votes

of votes

cast)

cast)

cast)

cast)

cast)

 

 

 

 

 

 

 

 

RESOLUTIONS SUBMITTED TO ORDINARY SHAREHOLDERS' MEETING

1.

Review and approval of the statutory financial statements for the fiscal year ended November 30, 2020

Adopted

22,256,952

-

22,239,308

540

17,104

83.10%

 

99.998%

0.002%

0.077%

2.

Appropriation of earnings for the fiscal year ended November 30, 2020

Adopted

22,256,952

-

22,215,275

41,540

37

83.10%

 

99.81%

0.19%

0.00%

3.

Examination and approval of the consolidated financial statements for the fiscal year ended November 30, 2020

Adopted

22,256,952

-

22,239,308

540

17,104

83.10%

 

99.998%

0.002%

0.077%

4.

Review and approval of agreements referred to in Article L. 225-38 of the Commercial Code

Adopted

22,256,952

-

22,224,110

540

37

83.10%

 

100.00%

0.00%

0.00%

5.

Approval of the compensation policy for the Chairman and Chief Executive Officer

Adopted

22,206,452

50,000

22,046,453

159,045

1,454

82.86%

0.23%

99.28%

0.72%

0.01%

6.

Approval of the remuneration policy for directors

Adopted

22,256,452

500

22,198,640

57,219

593

83.09%

0.00%

99.74%

0.26%

0.00%

7.

Approval of fixed, variable and exceptional items making up the total compensation and benefits of any kind paid during the fiscal year ended November 30, 2020 or allocated for the same fiscal year to the Chairman - Chief Executive Officer

Adopted

22,206,952

50,000

20,900,426

1,217,348

89,180

82.86%

0.00%

94.50%

5.50%

0.40%

8.

Approval of the information mentioned in Article L.22-10-9 -I of the Commercial Code

Adopted

22,256,952

-

22,224,087

32,828

37

83.10.%

 

99.85%

0.15%

0.00%

9.

Recognition of the expiration of the term of office of Mr. Nordine HACHEMI, renewal of the term of office of Mr. Nordine HACHEMI for a period of three years

Adopted

22,256,952

-

20,998,776

1,588,139

37

83.10%

 

92.87%

7.14%

0.00%

10.

Recognition of the expiration of the director mandate of Mr. André MARTINEZ, appointment of a new director for a period of three years

Adopted

22,256,952

-

22,170,970

85,880

102

83.10%

 

99.61%

0.37%

0.00%

11.

Recognition of the expiration of the term of office of Mrs. Sylvie CHARLES, renewal of the term of office of Mrs. Sylvie CHARLES for a period of three years

Adopted

22,256,952

-

22,181,760

75,155

37

83.10%

 

99.66%

0.34%

0.00%

12.

Recognition of the expiration of the term of office of Mrs. Sophie LOMBARD, renewal of the term of office of Mrs. Sophie LOMBARD for a period of three years

Adopted

22,256,952

-

21,990,057

266,858

37

83.10%

 

98.80%

1.20%

0.00%

13.

Recognition of the expiration of the term of office of Mrs. Lucile RIBOT, renewal of the term of office of Mrs. Lucile RIBOT for a period of three years

Adopted

22,256,952

-

22,238,216

18,699

37

 

 

 

83.10%

 

99.92%

0.08%

0.00%

14.

Recognition of the expiration of the mandate of director representing the employee shareholders of Mrs. Karine NORMAND, renewal of the mandate of director of Mrs. Karine NORMAND for a period of three years

Adopted

22,256,952

-

22,237,292

18,699

1,051

83.10%

 

99.92%

0.08%

0.00%

15.

Recognition of the expiration of the term of office as director of Mrs. Caroline PUECHOULTRES, appointment of a new director for a period of three years

Adopted

22,256,952

-

22,140,078

116,837

37

83.10%

 

99.48%

0.53%

0.00%

16.

 

Recognition of the expiration of the terms of office of ERNST & YOUNG AUDIT, statutory auditor of the Company and of AUDITEX, deputy auditor of the Company; appointment of statutory auditors for a period of six fiscal years

Adopted

22,256,952

-

20,107,516

2,149,399

37

83.10%

 

90.34%

9.66%

0.00%

17.

Recognition of the expiration of the mandates of DELOITTE & ASSOCIES, statutory auditor of the Company and of B.E.A.S., deputy auditor of the Company; appointment of statutory auditors for a period of six fiscal years

Adopted

22,256,952

-

22,244,175

12,740

37

83.10%

 

99.94%

0.06%

0.00%

18.

Authorization to be granted to the board of directors, for a period of eighteen months, for the purpose of purchasing by the company its own shares

Adopted

22,256,952

-

22,205,810

20,661

30,481

83.10%

 

99.91%

0.09%

0,14%

31.

Powers for completing formalities

Adopted

22,256,952

-

22,256,377

540

35

 

83.10%

 

100.00%

0.00%

0.00%

 

RESOLUTIONS SUBMITTED TO EXTRAORDINARY SHAREHOLDERS' MEETING

19.

Authorization to be granted to the board of directors, for a period of twenty-six months, for the purpose of canceling shares held by the Company following the repurchase of its own shares

Adopted

22 256 952

-

22,255,296

1,619

37

83,10%

 

10.00%

0.00%

0.00%

20.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of increasing the share capital by incorporation of reserves or premiums

Adopted

22 256 952

-

22,256,375

540

37

83,10%

 

100.00%

0.00%

0.00%

21.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares and / or equity securities giving access to other equity securities or giving the right to the allocation of debt securities and / or marketable securities giving access to equity securities to be issued by the Company with maintenance of shareholders' preferential subscription rights

Adopted

22 256 952

-

21,171,112

85,803

37

83,10%

 

9.61%

0.39%

0.00%

22.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares and / or equity securities giving access to other equity securities or giving the right to the allocation of debt securities and / or marketable securities giving access to equity securities to be issued by the Company, with cancellation of shareholders' preferential subscription rights, within the framework of public offers other than those referred to in l Article L.411-2 of the Monetary and Financial Code

Adopted

22 256 952

-

21,603,813

653,813

37

83,10%

 

97.06%

2.94%

0.00%

23.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing ordinary shares, and / or equity securities giving access to other equity securities or giving rights to the allocation of debt securities, and / or marketable securities giving access to equity securities to be issued by the Company, with cancellation of shareholders' preferential subscription rights, within the framework of public offers referred to in 1 of Article L.411-2 of the Monetary and Financial Code

Adopted

22 256 952

 

21,098,191

1,158,724

37

83,10%

 

94.80%

5.21%

0.00%

24.

Authorization to be granted to the board of directors, for a period of twenty-six months, in the event of the issue of ordinary shares, and / or equity securities giving access to other equity securities or giving right to the allocation of debt securities, and / or marketable securities giving access to equity securities to be issued by the Company with cancellation of shareholders' preferential subscription rights, to set the issue price according to the terms set by the general meeting within the limit of 10% of the share capital

Adopted

22 256 952

-

21,052,836

1,204,079

37

83,10%

 

94.60%

5.41%

0.00%

25.

Authorization to be granted to the board of directors, for a period of twenty-six months, in order to increase the number of securities to be issued in the event of a capital increase with maintenance or with elimination of shareholders' preferential subscription rights

Adopted

22 256 952

-

21,044,163

1,212,752

37

83,10%

 

94.45%

5.45%

0.00%

26.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares or equity securities giving access to other equity securities or giving the right to the allocation debt securities as remuneration for contributions in kind of equity securities or marketable securities giving access to the capital within the limit of 10% of the share capital

Adopted

22 256 952

-

22,131,859

123,066

37

83,10%

 

99.44%

0.56%

0.00%

27.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares and / or equity securities giving access to other equity securities or to the allocation debt securities as remuneration for securities contributed to any public exchange offer initiated by the Company

rejected

22 256 952

-

14,168,813

8,088,102

37

83,10%

 

63.66%

36.34%

0.00%

28.

Delegation of authority to be granted to the board of directors, for a period of twenty-six months, for the purpose of issuing shares and / or securities giving access to the Company's shares to be issued with cancellation of the preferential subscription right of shareholders, for the benefit of members of the group's Company Savings Plan (s) for an amount of 3% of the capital

Adopted

22 256 952

-

22,131,871

125,044

37

83,10%

 

99.44%

0.56%

0.00%

29.

Authorization to be granted to the board of directors, for a period of thirty-eight months, for the purpose of allocating free shares to be issued or existing for the benefit of employees and / or executive corporate officers of the Company and related entities

Adopted

22 256 952

-

21,589,949

579,240

87,763

83,10%

 

97.39%

2.61%

0.39%

30.

Setting of the general ceilings for delegations of authority at a nominal amount of (i) € 2,270,000 for all capital increases through the issue of shares or equity securities giving access to other equity securities or securities giving access to equity securities to be issued, (ii) € 568,000 for capital increases through the issue of shares or equity securities giving access to other equity securities or securities securities giving access to equity securities to be issued with cancellation of preferential subscription rights and (iii) € 500,000,000, for issues of debt securities giving the right to the allocation of a capital or debt security; setting specific ceilings for capital increases likely to result from the allocation of free shares

Adopted

22 256 952

 

22,129,522

127,393

37

83,10%

-

99.43%

0.57%

0.00%

 

This press release is available at www.kaufmanbroad.fr

Contacts

Chief Financial Officer

Bruno Coche

+33 (0)1 41 43 44 73

Infos-invest@ketb.com

 

Press Relations

DGM Conseil

Thomas Roborel de Climens - +33 (0)6 14 50 15 84

thomasdeclimens@dgm-conseil.fr

 

Kaufman & Broad: Emmeline Cacitti

+33 (0)6 72 42 66 24 / ecacitti@ketb.com

 

About Kaufman & Broad - Kaufman & Broad has been designing, developing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years. Kaufman & Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.

 

The Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No. 21-0239 on March 31, 2021.  It is available on the AMF (www.amf-france.org) and Kaufman & Broad (www.kaufmanbroad.fr) websites. It contains a detailed description of Kaufman & Broad's business activities, results, and outlook, as well as the associated risk factors. Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 4 of the Registration Document. The occurrence of one or more of these risks might have a material adverse impact on the Kaufman & Broad.

 


Regulatory filing PDF file

File: AGM 6, May 2021 results

1198850  20-May-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1198850&application_name=news&site_id=symex

22/07/2021 14:59
22/07/2021 14:58
12/07/2021 18:45
06/07/2021 16:15
20/05/2021 09:56
20/05/2021 09:55
06/05/2021 14:45
06/05/2021 14:28
06/05/2021 14:06
15/04/2021 18:26